Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study.
Heckmann
S M
SM
Heckmann
J G
JG
Ungethüm
A
A
Hujoel
P
P
Hummel
T
T
D000368:Aged; D000588:Amines / Q000627:therapeutic use*; D002054:Burning Mouth Syndrome / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D017211:Treatment Failure; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin